Where did you hear of this? A google search returns nothing on "BMQ-350".
He may have meant “BXQ-350”?Mike B
I suspected it was a typo of some sort, thanks Mike.
NCT02859857Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumorshttps://www.usatoday.com/story/news/nation-now/2018/08/09/researchers-test-experimental-drug-could-answer-cancer/948394002/
http://abstracts.asco.org/214/AbstView_214_217587.html (ASCO 2018)https://www.bexionpharma.com/press-releases/bexion-pharmaceuticals-inc-announces-data-at-2018-asco-annual-meeting-from-ongoing-phase-i-bxq-350-clinical-trial/The actual poster from the ASCO conference would be more valuable than these brief summaries, but I don't have access to it.
Where did you hear of this? A google search returns nothing on "BMQ-350".
ReplyDeleteHe may have meant “BXQ-350”?
ReplyDeleteMike B
I suspected it was a typo of some sort, thanks Mike.
DeleteNCT02859857
ReplyDeletePhase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors
https://www.usatoday.com/story/news/nation-now/2018/08/09/researchers-test-experimental-drug-could-answer-cancer/948394002/
http://abstracts.asco.org/214/AbstView_214_217587.html (ASCO 2018)
ReplyDeletehttps://www.bexionpharma.com/press-releases/bexion-pharmaceuticals-inc-announces-data-at-2018-asco-annual-meeting-from-ongoing-phase-i-bxq-350-clinical-trial/
The actual poster from the ASCO conference would be more valuable than these brief summaries, but I don't have access to it.